STEK · XBRL financial data
Stemtech financial statements, every fiscal year
The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (STEK's year ends in late December)
| In millions of dollars | Aug 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | 4 | 5 | 5 | — | — |
| Revenue from contracts with customers | — | 4 | 5 | 5 | 5 | 3 |
| Cost of revenue | — | 1 | 1 | 1 | 1 | 1 |
| Cost of goods and services sold | — | 1 | 1 | 1 | — | — |
| Gross profit | — | 3 | 3 | 4 | 4 | 2 |
| Research and development | — | — | 0 | 0 | 0 | 0 |
| General and administrative | 0 | 5 | 7 | 6 | 5 | 5 |
| Total operating expenses | — | 7 | 8 | 8 | 6 | 5 |
| Operating income (loss) | (0) | (3) | (5) | (4) | (2) | (3) |
| Interest expense | 0 | 8 | — | 5 | 2 | 1 |
| Other income (expense) | — | (0) | 0 | 0 | 0 | 0 |
| Income tax expense (benefit) | — | 0 | 0 | 0 | 0 | 0 |
| Net income (loss) | (0) | (7) | (9) | (5) | (4) | (4) |
| Earnings per share, basic USD per share | — | (0.19) | (0.19) | (0.07) | (0.03) | (0.02) |
| Earnings per share, diluted USD per share | — | (0.19) | (0.19) | (0.07) | (0.03) | (0.02) |
| Weighted average shares, basic millions of shares | — | 38 | 46 | 83 | 119 | 170 |
| Weighted average shares, diluted millions of shares | — | 38 | 46 | 83 | 119 | 170 |
Balance sheet
CSVFiscal years (STEK's year ends in late December)
| In millions of dollars | Aug 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 0 | 1 | 0 | 0 | 0 | 0 |
| Inventory | — | 0 | 0 | 0 | 0 | 0 |
| Prepaid and other current assets | — | 0 | 0 | 0 | 0 | 0 |
| Total current assets | 0 | 2 | 1 | 0 | 1 | 0 |
| Property and equipment, net | — | 0 | 0 | 0 | 0 | 0 |
| Right-of-use asset | — | 0 | 0 | 0 | 0 | 0 |
| Goodwill | — | 0 | 0 | 0 | 0 | 0 |
| Total assets | 0 | 6 | 4 | 4 | 4 | 3 |
| Accrued liabilities | — | 0 | — | — | 0 | — |
| Total current liabilities | — | 9 | 7 | 6 | 9 | 11 |
| Lease liability, non-current | — | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 0 | 10 | 7 | 6 | 9 | 11 |
| Accumulated deficit | (0) | (13) | (22) | (27) | (31) | (35) |
| Total stockholders' equity | (0) | (3) | (2) | (2) | (4) | (7) |
| Total liabilities and equity | 0 | 6 | 4 | 4 | 4 | 3 |
| Common shares outstanding (cover page) millions of shares | 11 | 45 | 61 | 117 | 142 | 2,068 |
Cash flows
CSVFiscal years (STEK's year ends in late December)
| In millions of dollars | Aug 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (0) | (7) | (9) | (5) | (4) | (4) |
| Stock-based compensation | — | 1 | 4 | 0 | 0 | 0 |
| Depreciation and amortization | — | 0 | 0 | 1 | 0 | 0 |
| Net cash from operating activities | (0) | (2) | (1) | (2) | (1) | (0) |
| Purchases of property and equipment | — | — | — | 0 | 0 | 0 |
| Net cash from investing activities | — | — | — | 0 | 0 | 0 |
| Proceeds from issuing common stock | — | 0 | 0 | 0 | 0 | 0 |
| Net cash from financing activities | 0 | 3 | 0 | 2 | 1 | 0 |
| Net change in cash | 0 | 1 | (1) | (0) | 0 | (0) |
Compare with peers
SIC 5122 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Stemtech | 0.2 | 0.6 | (0.1)* | 3.0B | 4.5 quarters | 10-QJun 30, 2026 |
| Cosmos Health | 1.8 | 19 | (1.7)* | 100.6M | 1.1 quarters | 10-QJun 30, 2026 |
| HWH International | 1.5 | 0.1 | 0.5* | 7.7M | — | 10-QJun 30, 2026 |
| Sharing Services Global | 0.7 | 2.1 | (0.4)* | 309,652 | 1.7 quarters | 10-QSep 30, 2024 |
| DataMeds AI | 2.5 | 1.8 | (2.9)* | 3.1M | 0.8 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.